377 related articles for article (PubMed ID: 8418053)
1. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
Wu HY; Russell MW
Infect Immun; 1993 Jan; 61(1):314-22. PubMed ID: 8418053
[TBL] [Abstract][Full Text] [Related]
2. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.
Russell MW; Wu HY
Infect Immun; 1991 Nov; 59(11):4061-70. PubMed ID: 1937766
[TBL] [Abstract][Full Text] [Related]
3. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.
Wu HY; Russell MW
Vaccine; 1998; 16(2-3):286-92. PubMed ID: 9607044
[TBL] [Abstract][Full Text] [Related]
4. Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.
Toida N; Hajishengallis G; Wu HY; Russell MW
Infect Immun; 1997 Mar; 65(3):909-15. PubMed ID: 9038296
[TBL] [Abstract][Full Text] [Related]
5. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin.
Katz J; Harmon CC; Buckner GP; Richardson GJ; Russell MW; Michalek SM
Infect Immun; 1993 May; 61(5):1964-71. PubMed ID: 8478086
[TBL] [Abstract][Full Text] [Related]
6. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Infect Immun; 2000 Oct; 68(10):5749-55. PubMed ID: 10992481
[TBL] [Abstract][Full Text] [Related]
7. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.
Russell MW; Moldoveanu Z; White PL; Sibert GJ; Mestecky J; Michalek S M
Infect Immun; 1996 Apr; 64(4):1272-83. PubMed ID: 8606090
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.
Harokopakis E; Hajishengallis G; Michalek SM
Infect Immun; 1998 Sep; 66(9):4299-304. PubMed ID: 9712781
[TBL] [Abstract][Full Text] [Related]
9. Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin-based chimeric protein.
Gockel CM; Russell MW
Immunology; 2005 Dec; 116(4):477-86. PubMed ID: 16313361
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
[TBL] [Abstract][Full Text] [Related]
11. Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunization.
Wu HY; Nikolova EB; Beagley KW; Eldridge JH; Russell MW
Infect Immun; 1997 Jan; 65(1):227-35. PubMed ID: 8975916
[TBL] [Abstract][Full Text] [Related]
12. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.
Menge AC; Michalek SM; Russell MW; Mestecky J
Infect Immun; 1993 May; 61(5):2162-71. PubMed ID: 8478106
[TBL] [Abstract][Full Text] [Related]
13. Long-term persistence and recall of immune responses in aged mice after mucosal immunization.
Harrod T; Martin M; Russell MW
Oral Microbiol Immunol; 2001 Jun; 16(3):170-7. PubMed ID: 11358539
[TBL] [Abstract][Full Text] [Related]
14. Generation of female genital tract antibody responses by local or central (common) mucosal immunization.
Wu HY; Abdu S; Stinson D; Russell MW
Infect Immun; 2000 Oct; 68(10):5539-45. PubMed ID: 10992451
[TBL] [Abstract][Full Text] [Related]
15. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
Price GA; Russell MW; Cornelissen CN
Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
[TBL] [Abstract][Full Text] [Related]
16. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
[TBL] [Abstract][Full Text] [Related]
17. Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B subunit, and effects of pre-existing anti-CT immunity.
Wu HY; Russell MW
Vaccine; 1994; 12(3):215-22. PubMed ID: 8165853
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.
Saito M; Otake S; Ohmura M; Hirasawa M; Takada K; Mega J; Takahashi I; Kiyono H; McGhee JR; Takeda Y; Yamamoto M
J Infect Dis; 2001 Mar; 183(5):823-6. PubMed ID: 11181162
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.
Childers NK; Miller KL; Tong G; Llarena JC; Greenway T; Ulrich JT; Michalek SM
Infect Immun; 2000 Oct; 68(10):5509-16. PubMed ID: 10992447
[TBL] [Abstract][Full Text] [Related]
20. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
